We found significantly increased concentrations of CX3CL1 from the serum of the SSc patients (2.0 ng/ml (SD 2.5)) as compared to the healthy controls (1.1 ng/ml (SD 1.4), p = 0.002) (Fig 1B). The gene discussed is CX3CL1; the disease is systemic sclerosis.